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Background: Obesity may affect both biochemical thyroid function tests; and thyroid
morphology, as assessed using ultrasound scans (US). The aim of the present pilot
study was to explore whether weight loss achieved by bariatric surgery alters thyroid
US morphology including gray-scale measurements; and/or function in euthyroid adults
with severe obesity.
Methods: Euthyroid adults (>18 years) with body mass index (BMI) ≥40 kg/m2
and negative thyroid peroxidase antibodies were assessed at baseline (pre-surgery)
and after achieving at least 5% weight loss of their baseline body weight following
bariatric surgery. Anthropometric assessments, biochemical/hormonal measurements
(TSH, free-T4, free-T3, reverse-T3, and leptin) and thyroid US with gray-scale histogram
analysis were performed at the baseline and post-surgery follow-up.
Results: Ten Caucasian, euthyroid patients (women/men: 8/2; age: 48.6 ± 3.1 years;
BMI: 51.4 ± 1.8 kg/m2) successfully completed this study with significantly decreased
body weight (>5%weight loss), waist circumference and serum leptin levels post-surgery
(mean post-surgery follow-up duration: 16.5 ± 2.5 months). In parallel to the observed
bariatric-induced weight loss, thyroid US echogenicity increased by 25% (p = 0.03),
without significant changes in thyroid volume. No significant changes in thyroid function
tests were detected. No significant correlations were observed between the increase
in thyroid echogenicity and the decreases in anthropometric parameters and circulating
leptin.
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Conclusion: Our results indicate that in euthyroid adults with severe obesity, marked
weight loss achieved by bariatric surgery is associated with a parallel significant increase
in the thyroid US echogenicity, suggesting that morphological changes of the thyroid in
obesity are reversible with weight loss.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03048708
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INTRODUCTION
By 2025, the global prevalence of obesity is expected to reach 18
and 21% in men and women, respectively, with a progressively
increasing burden of obesity-related disease (1, 2). Thyroid
function tests can be variably altered in patients with obesity (3–
6). Whether such obesity-related changes of the thyroid function
are a contributing cause, or a consequence of obesity is not
always clear (3–6). Emerging evidence further suggests that the
thyroid morphology can be also affected in obesity (7, 8). Indeed,
a cross-sectional study in 186 overweight/obese children has
documented that obesity is often associated with changes in
the thyroid morphology, which can be identified by ultrasound
scanning (US) and do not appear to be related to thyroid
autoimmunity (e.g., thyroid hypo-echogenicity resembling, but
not caused by autoimmune thyroiditis, AIT) (7).
Bariatric surgery remains the most effective treatment
for obesity and is considered to induce a spectrum of
metabolic/endocrine changes (9, 10). Despite the markedly
increased number of patients treated by bariatric surgery in the
past decade, only a few studies have investigated the potential
effects of bariatric-induced weight loss on thyroid function (11,
12). To our knowledge, there are currently no studies on the
potential changes in the morphology of the thyroid in patients
with severe obesity after bariatric surgery. Thus, the aim of
the present pilot study was to explore whether weight loss
achieved by bariatric surgery may result in changes of the thyroid
morphology and/or function in euthyroid adults with severe
obesity.
METHODS AND MATERIALS
Study Cohort
The Coventry/Warwickshire Research Ethics Committee
approved this study (reference: 11/WM/0085), and all
participants provided written informed consent in accordance
with the Declaration of Helsinki. The study cohort was recruited
from adults (>18 years) with body mass index (BMI) ≥40
kg/m2 (Class 3, severe obesity) and negative thyroid peroxidase
antibodies (TPO-Abs), attending the obesity clinics at the
University Hospitals Coventry andWarwickshire (UHCW) NHS
Trust. The study exclusion criteria included known or newly
Abbreviations: AIT, autoimmune thyroiditis; fT4, free-T4; fT3, free-T3; rT3,
reverse-T3; ROI, regions of interest; RYGB, Roux-en-Y gastric bypass; TPO-
Abs, thyroid peroxidase antibodies; UHCW, University Hospitals Coventry and
Warwickshire NHS Trust.
detected thyroid disorders during screening, obesity secondary to
primary endocrine/systemic disease (e.g., Cushing’s syndrome)
and any inflammatory disease (e.g., rheumatoid arthritis), as well
as treatment with anti-inflammatory drugs (e.g., corticosteroids).
For the purposes of this study, all recruited patients were
prospectively followed at UHCW and were assessed at baseline
(pre-surgery) and after achieving at least 5% weight loss of their
baseline body weight following bariatric surgery. The latter was
considered the minimum clinically relevant weight loss in the
context of the present study.
Anthropometric Assessments
Anthropometric measurements were performed by trained staff
at baseline and post-surgery follow-up, as per study protocol.
Body weight (without shoes and heavy clothing) was measured
to the nearest 0.5 kilogram (kg) using a digital platform scale
suitable for patients with severe obesity (Seca, Germany). Waist
circumference was measured to the nearest 1 cm with an inelastic
measuring tape at the minimum circumference between the
lower margin of the last rib and the superior iliac crest, with the
participant in the upright position and at the end of expiration.
Biochemical/Hormonal Analyses
Blood samples for biochemical assessments were obtained at the
baseline and after post-surgery weight loss >5% was achieved.
Samples were collected in the morning (8–10 am) after ≥10 h
of overnight fasting. Serum/plasma samples were prepared and
aliquoted immediately, and aliquots were stored at −80◦C until
assayed.
Routine biochemical markers were analyzed at the UHCW
certified biochemistry laboratories. Normal ranges are given for
TSH as 0.27–4.2 mIU/L, free-T4 (fT4) as 9–26 pmol/L, and free-
T3 (fT3) as 2.8–7.1 pmol/L. Circulating levels of reverse-T3 (rT3)
weremeasured by a competitive inhibition enzyme immunoassay
[Caltag-Medsystems Ltd; inter- and intra-assay coefficients of
variation (CV): 12 and 10%, respectively]. Serum leptin was
measured using ELISA (human leptin Quantikine ELISA, Bio-
Techne; inter- and intra-assay CV: 5.4 and 3.3%, respectively),
according to the manufacturer’s protocol.
Thyroid Ultrasound (US) and Gray Scale
Measurements
US examinations included gray-scale histogram analyses, as
previously described (13). All thyroid US examinations were
performed by the same two Consultant Radiologists with
extensive experience in thyroid imaging, using a 7.5 MHz
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transducer (GE Healthcare Medical Systems US, Logic 8 & E9,
USA). Echogenicity was assessed using sagittal images from the
right thyroid lobe. The respective regions of interest (ROI) were
chosen in an area in the upper right lobe with control in nearby
neck muscle. Chosen ROIs were verified by an independent
Radiologist. Thyroid volume was calculated as the respective
largest diameters (length ∗ width ∗ depth) ∗0.479 of the left lobe,
the right lobe and the isthmus. The mean echogenicity (density)
of the thyroid parenchyma was expressed in gray-scales relative
to the control muscle echogenicity, as determined on the US
gray-scale histogram analysis.
Statistical Analysis
Data are presented as means± standard error (SEM). Normality
assumptions were assessed by P-P plots. Paired sample t-tests or
Wilcoxon Sign Rank tests were used to compare baseline and
longitudinal parameters, as appropriate. Correlations between
continuous variables with and without normal distribution were
tested by Pearson r or Spearman’s rho coefficients, respectively.
P-values are based on two-sided tests. Significance was set at
p < 0.05. Data analyses were performed using IBM SPSS v.22
(Chicago, Illinois, USA).
RESULTS
A total of 10 euthyroid, Caucasian adults with severe obesity met
the study inclusion/exclusion criteria and successfully completed
this study (women/men: 8/2; age: 48.6 ± 3.1 years). Of these
participants, five underwent a laparoscopic adjustable gastric
band procedure, while one sleeve gastrectomy and four a Roux-
en-Y gastric bypass (RYGB). All bariatric procedures were
performed by experienced bariatric surgeons, using standard
techniques. No complications occurred in the study patients.
Mean duration between baseline assessment and post-surgery
follow-up was 16.5 ± 2.5 months (mean weight loss: 30.1 ±
6.0 kg).
Table 1 presents the changes in the study-pertinent
characteristics of the participants between the baseline and
post-surgery follow-up assessments, with significant changes
in body weight, BMI, waist circumference and serum leptin
levels, as expected. In parallel to the post-surgical weight loss,
a significant increase was detected in the echogenicity of the
thyroid parenchyma in these euthyroid patients, as expressed
in gray-scales relative to the muscle echogenicity from the
US gray-scale histogram analysis (Table 1, Figure 1). Thyroid
volume did not change following bariatric surgery, and there
were no significant changes in thyroid function tests (Table 1).
Representative thyroid ultrasound scanning images before and
after bariatric surgery for a study participant who achieved 18%
body weight loss following bariatric surgery is presented in
Supplementary Figure S1.
Finally, at baseline before bariatric surgery there was a
statistically significant negative correlation between the mean
gray scale measurements and BMI (r = −0.64, p = 0.045),
but not with thyroid volume (p = 0.12), thyroid function tests
or leptin (all p >0.15). The observed negative correlation of
the mean gray scale measurements at baseline disappeared after
TABLE 1 | Changes in key relevant characteristics of the study patients (n = 10)
between the baseline and post-surgery follow-up (after at least 5% weight loss
was achieved) assessments.
Variable Baseline Post-surgery follow-up P-value
Body weight (kg) 135.8 ± 6.0 105.7 ± 5.2** 0.001
BMI (kg/m2) 51.4 ± 1.8 40.0 ± 1.7** 0.001
WC (cm) 131.7 ± 6.4 111.0 ± 2.4** 0.006
Leptin (µg/L) 88.3 ± 13.9 41.6 ± 11.1** 0.001
TSH (mIU/L) 2.2 ± 0.3 1.5 ± 0.3 0.16
fT4 (pmol/L) 15.1 ± 0.8 14.8 ± 1.0 0.97
fT3 (pmol/L) 4.9 ± 0.3 4.7 ± 0.2 0.67
rT3 (pg/ml) 175.6 ± 31.8 196.2 ± 26.1 0.52
Thyroid echogenicitya 1.26 ± 0.1 1.58 ± 0.1* 0.03
Thyroid volume (mL) 9.3 ± 1.1 9.4 ± 0.8 0.92
Data are presented as mean values ± standard error of the mean (SEM). *P < 0.05 and
**P < 0.01 for the comparison between the baseline and post-surgery follow-up mean
values by paired sample t-test or Wilcoxon signed-rank test.
aMean echogenicity (density) of the thyroid parenchyma in gray-scales relative to the
muscle echogenicity, as determined by the gray-scale histogram analysis on the thyroid
ultrasound scanning.
BMI, body mass index; WC, waist circumference; TSH, thyroid-stimulating hormone; fT4,
free-T4; fT3, free-T3; rT3, reverse-T3.
bariatric-induced weight loss (r = 0.11, p = 0.77). Relative
to baseline comparisons showed no significant correlation of
the mean greyscale measurements with BMI (r = −0.26, p
= 0.48). Overall, no significant correlations were observed
between the detected increase in thyroid echogenicity and
changes in anthropometric parameters and circulating leptin
levels.
DISCUSSION
Our study presents novel, prospective data showing that in
euthyroid adults with severe obesity, clinically significant weight
loss achieved by bariatric surgery is associated with a significant
increase in the echogenicity of the thyroid gland, as assessed
on thyroid US. This finding is supported by previous studies
which have shown that patients with obesity may exhibit hypo-
echogenicity of the thyroid parenchyma (7, 8). Indeed, Radetti
et al. have shown that overweight/obese children may frequently
present with a hypo-echoic thyroid US pattern suggestive of AIT,
in the absence of positive thyroid auto-antibodies (7). Moreover,
in adults, Rotondi et al. have documented an unexplained
hypo-echoic thyroid US pattern (in the absence of justifying
thyroid disorders and negative thyroid auto-antibodies), which
was present in 64.8% of the tested patients with severe obesity
but only in 1.9% of the non-obese controls (8). As such, Rotondi
et al. concluded that severe obesity may be associated with a
hypo-echoic thyroid US pattern which can decrease the accuracy
of the thyroid US for diagnosing AIT in patients with severe
obesity (8). Our findings expand on these observations by
showing a 25% significant increase of thyroid echogenicity on
US following bariatric-induced weight loss, thus suggesting that
obesity-related morphological changes of the thyroid can be
reversible with weight loss.
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FIGURE 1 | (A) Decrease in the absolute body weight (kg) of the
euthyroid study patients (n = 10) between the baseline (pre- bariatric surgery)
and follow-up (post bariatric surgery; after achieving at least 5% weight loss;
mean duration between visits 16.5 ± 2.5 months) assessments.
(B) Respective increase in the echogenicity of the thyroid parenchyma in the
study patients between the baseline and post-surgery follow-up assessments,
as expressed in gray-scales relative to the muscle echogenicity from the
performed ultrasound scanning gray-scale histogram analysis.
Fat accumulation in the thyroid of patients with severe obesity
has been previously hypothesized as a potential explanation for
thyroid morphological changes (7, 8). However, on US, fat tissue
accumulation would be expected to be hyper-echoic, i.e.,result
in higher, rather than lower gray-scale readings. Therefore,
in agreement with previous studies (7, 8), we also suggest
that the hypo-echoic thyroid US pattern observed in severely
obese patients might be attributed to the presence of obesity-
related low-grade inflammation (and thus, potential infiltration
of various tissues, including the thyroid, with water-containing,
low-echoic pro-inflammatory cells), which is a key underlying
mechanism in the pathophysiology of obesity (2). The observed
increase in the thyroid US echogenicity following bariatric-
induced weight loss in our study is supporting this hypothesis,
although further studies including the sampling of thyroid tissue
biopsies are desirable to prove this concept.
Thyroid function tests did not significantly change in the here
investigated patients following bariatric surgery-induced weight
loss. In contrast, a retrospective cohort analysis of 55 euthyroid
patients with severe obesity has previously reported that weight
loss after RYGB significantly increases circulating fT4 levels,
without affecting TSH (14). More recently, a large retrospective
observational study in 949 euthyroid patients with severe obesity
showed that bariatric surgery (laparoscopic adjustable gastric
band, sleeve gastrectomy or RYGB) can result in a decrease in
TSH levels, which is independently associated with the post-
surgery excess body weight loss and is greater in patients with
high-normal TSH (15). Overall, a recent meta-analysis on the
impact of bariatric surgery on the thyroid function in patients
with obesity has shown that decreased TSH, T3, and fT3 levels
can be expected in these patients post-op, without significant
changes in T4, fT4, and rT3 (12). The small sample size of
our bariatric cohort and the inclusion of only euthyroid adults
may account for the lack of significant changes in the thyroid
hormones measured in our study, although a trend to improved
TSH levels could be stated.
Finally, it is noteworthy that the underlying mechanisms
mediating thyroid function changes in obesity are not fully
clarified yet (3–6). Notably, leptin appears involved in these
mechanisms, since this pleiotropic adipokine, which regulates
satiety and body weight, has also been implicated in the
regulation of the thyroid axis/function in humans (3–6, 16–18).
In our study, there was no correlation between the noted increase
in the thyroid echogenicity and the decrease in circulating leptin
after the post-surgery weight loss. Large prospective studies are
needed to elucidate the exact effects of bariatric-induced weight
loss on the thyroid function of patients with obesity; and their
potential underlying associations to key adipokines, such as
leptin.
Study Limitations
The small sample size of our cohort is a limitation. However,
this pilot study was performed to guide future larger studies
in this field and, indeed, was able to address our primary
objective by detecting significant changes in the echogenicity
of the thyroid parenchyma following bariatric-induced weight
loss. Lack of a control group including patients with obesity that
have not undergone bariatric surgery may be also considered
as a study limitation. Moreover, due to the ethics approved
design/protocol of the present pilot study, we were not able to
further study the histopathological basis of the observed thyroid
US imaging findings [e.g., by obtaining fine-needle aspiration
cytology (FNAC) samples of the thyroid tissue or examining
thyroid tissue samples following total or hemi-thyroidectomy].
However, it should be also noted that thyroid FNAC is not
regarded as an appropriate technique method for elucidating the
histopathological basis of such thyroid US findings, particularly
for assessing the thyroid fat content (7, 8). Finally, all study
participants were Caucasians, thus our findings cannot be
directly extrapolated to subjects of other ethnic backgrounds.
Conclusion
To the best of our knowledge, this is the first study in
euthyroid adults with severe obesity showing that marked weight
loss achieved by bariatric surgery is followed by a parallel
significant increase in the thyroid US echogenicity. This novel
observation expands on the existing evidence regarding changes
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of the thyroid morphology in obesity and is relevant to clinical
practice, given that thyroid US is the most commonly used
non-invasive tool for diagnosing thyroid disorders. Further, the
number of patients treated with bariatric surgery is expected
to keep increasing due to the ongoing obesity epidemic. As
such, clinicians managing such patients should be aware that
during the pre- and post-surgery follow-up it is possible to
detect the presence of a hypo-echoic pattern on thyroid US
that is not explained by thyroid autoimmunity and can subside
with weight loss. Indeed, this may have implications for the
diagnostic accuracy of thyroid US for AIT in patients with
severe obesity pre- and post-bariatric surgery. The findings of
this pilot study should be confirmed in future studies with
large bariatric cohorts, which may also explore whether different
bariatric operations induce differential effects on the thyroid
morphology.
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